ReviewWomen's health reports (New Rochelle, N.Y.)
Improving Cervical Cancer Screening Participation Through Human Papillomavirus Self-Sampling: A Scoping Review of Evidence in Underserved Populations.
Review in Women's health reports (New Rochelle, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer remains the fourth most common cancer among women worldwide, with an estimated 660,000 new cases and 348,000 deaths in 2022. Despite the demonstrated efficacy of established screening programs, participation remains disproportionately low in underserved populations due to structural, cultural, and personal barriers. Human papillomavirus (HPV) self-sampling has emerged as a promising strategy to improve access to cervical cancer screening for these groups. Objective: To map and synthesize evidence on the acceptability and implementation of HPV self-sampling for cervical cancer screening among marginalized populations. Methods: A scoping review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines was conducted. PubMed and Embase were searched for literature published between 2002 and 2025. Studies were eligible if they reported acceptability, feasibility, or participant preferences for HPV self-sampling in at least one defined marginalized population. Data were synthesized narratively. Restriction to two databases is acknowledged as a methodological limitation. Results: Ten studies spanning eight countries and involving over 6400 participants were included. Acceptance rates ranged from 21% to 98%. Higher acceptance was consistently associated with community-driven implementation models incorporating community health worker involvement, culturally tailored education, and home-visit options. Privacy, autonomy, and convenience were key facilitators; low literacy, fear of results, and health care mistrust were the most common barriers. Conclusions: HPV self-sampling can achieve high acceptance in marginalized communities when implemented through culturally sensitive, community-engaged programs with adequate support infrastructure. Integrating education, navigation support, and low-barrier follow-up care offers significant potential for advancing health equity in cervical cancer prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.